{"id":3411,"date":"2021-03-25T11:17:00","date_gmt":"2021-03-25T10:17:00","guid":{"rendered":"http:\/\/leo-foundation.org\/en\/?p=3858"},"modified":"2022-03-24T14:48:35","modified_gmt":"2022-03-24T13:48:35","slug":"aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar","status":"publish","type":"post","link":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/","title":{"rendered":"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r"},"content":{"rendered":"\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div style=\"height:55px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"text-cols text-cols-columns-1 text-cols align\" data-block_60376f96dc084>\n  \n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<p><em>25. marts 2021<\/em><\/p>\n\n\n\n<p><strong><strong>I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet &#8211; og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.<\/strong><\/strong><\/p>\n\n\n\n<p>LEO Fondets \u00e5rsrapport samler op p\u00e5 resultaterne inden for Fondets tre overordnede aktivitetsomr\u00e5der: filantropiske uddelinger, engageret ejerskab og finansielle investeringer.<\/p>\n\n\n\n<div style=\"height:34px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><a href=\"https:\/\/issuu.com\/leofoundation\/docs\/leo_foundation_annual_report_final?fr=sNGM3NDMzNjY5MDc\" target=\"_blank\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/leo-foundation.org\/en\/wp-content\/uploads\/sites\/2\/2021\/03\/LEO_AR2020_Cover-1024x576.jpg\" alt=\"\" class=\"wp-image-3741\" width=\"512\" height=\"288\"\/><\/a><figcaption>Klik for at l\u00e6se \u00e5rsrapporten<\/figcaption><\/figure>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"text-cols text-cols-columns-1 text-cols align\" data-block_605dbb6b698b0>\n  \n\n<p>L\u00e6s meget mere om resultater og \u00e5rsrapport p\u00e5 vores engelske hjemmeside.<\/p>\n\n\n<\/div>\n\n<style type=\"text\/css\">\n  [data-block_605dbb6b698b0] p {\n    column-count: 1;\n    column-gap: 30px;\n  }\n<\/style>\n\n\n\n<div style=\"height:29px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-fill\"><a class=\"wp-block-button__link has-primary-coal-color has-primary-peach-background-color has-text-color has-background\" href=\"https:\/\/leo-foundation.org\/en\/2021\/03\/25\/annual-report-2020-resilience-and-commitment-in-an-extraordinary-year\/\" target=\"_blank\" rel=\"noreferrer noopener\">L\u00e6s mere<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:56px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong><em>Om LEO Fondet<\/em><\/strong><\/p>\n\n\n\n<p><em>LEO Fondet er en af Danmarks st\u00f8rste erhvervsdrivende fonde&nbsp;og engageret ejer af&nbsp;medicinalvirksomheden LEO Pharma.&nbsp;Fondet&nbsp;har som prim\u00e6rt form\u00e5l at sikre virksomhedens langsigtede udvikling og succes.&nbsp;<\/em><\/p>\n\n\n\n<p><em>Udover ejerskabet af LEO Pharma uddeler&nbsp;LEO&nbsp;Fondet filantropisk st\u00f8tte til international forskning i hud og hudsygdomme og arbejder for at g\u00f8re Danmark til et globalt fyrt\u00e5rn inden for hudforskning.&nbsp;<\/em><\/p>\n<\/div><\/div>\n\n\n<\/div>\n\n<style type=\"text\/css\">\n  [data-block_60376f96dc084] p {\n    column-count: 1;\n    column-gap: 30px;\n  }\n<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet &#8211; og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.<\/p>\n","protected":false},"author":4,"featured_media":3412,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3411","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r<\/title>\n<meta name=\"description\" content=\"I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet - og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r\" \/>\n<meta property=\"og:description\" content=\"I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet - og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/\" \/>\n<meta property=\"og:site_name\" content=\"LEO Fondet\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-25T10:17:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-24T13:48:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leo-foundation.org\/da\/wp-content\/uploads\/2021\/03\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2449\" \/>\n\t<meta property=\"og:image:height\" content=\"1632\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"signe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"signe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/\"},\"author\":{\"name\":\"signe\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/#\\\/schema\\\/person\\\/3b6acb35625fa72a6925067acbb019e3\"},\"headline\":\"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r\",\"datePublished\":\"2021-03-25T10:17:00+00:00\",\"dateModified\":\"2022-03-24T13:48:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/\"},\"wordCount\":177,\"image\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"da-DK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/\",\"url\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/\",\"name\":\"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg\",\"datePublished\":\"2021-03-25T10:17:00+00:00\",\"dateModified\":\"2022-03-24T13:48:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/#\\\/schema\\\/person\\\/3b6acb35625fa72a6925067acbb019e3\"},\"description\":\"I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet - og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#primaryimage\",\"url\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg\",\"contentUrl\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg\",\"width\":2449,\"height\":1632},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/2021\\\/03\\\/25\\\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Forside\",\"item\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/#website\",\"url\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/\",\"name\":\"LEO Fondet\",\"description\":\"Endnu en WordPress-blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/leo-foundation.org\\\/da\\\/#\\\/schema\\\/person\\\/3b6acb35625fa72a6925067acbb019e3\",\"name\":\"signe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g\",\"caption\":\"signe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r","description":"I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet - og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/","og_locale":"da_DK","og_type":"article","og_title":"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r","og_description":"I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet - og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.","og_url":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/","og_site_name":"LEO Fondet","article_published_time":"2021-03-25T10:17:00+00:00","article_modified_time":"2022-03-24T13:48:35+00:00","og_image":[{"width":2449,"height":1632,"url":"https:\/\/leo-foundation.org\/da\/wp-content\/uploads\/2021\/03\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg","type":"image\/jpeg"}],"author":"signe","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"signe","Estimeret l\u00e6setid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#article","isPartOf":{"@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/"},"author":{"name":"signe","@id":"https:\/\/leo-foundation.org\/da\/#\/schema\/person\/3b6acb35625fa72a6925067acbb019e3"},"headline":"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r","datePublished":"2021-03-25T10:17:00+00:00","dateModified":"2022-03-24T13:48:35+00:00","mainEntityOfPage":{"@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/"},"wordCount":177,"image":{"@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#primaryimage"},"thumbnailUrl":"https:\/\/leo-foundation.org\/da\/wp-content\/uploads\/2021\/03\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg","articleSection":["News"],"inLanguage":"da-DK"},{"@type":"WebPage","@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/","url":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/","name":"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r","isPartOf":{"@id":"https:\/\/leo-foundation.org\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#primaryimage"},"image":{"@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#primaryimage"},"thumbnailUrl":"https:\/\/leo-foundation.org\/da\/wp-content\/uploads\/2021\/03\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg","datePublished":"2021-03-25T10:17:00+00:00","dateModified":"2022-03-24T13:48:35+00:00","author":{"@id":"https:\/\/leo-foundation.org\/da\/#\/schema\/person\/3b6acb35625fa72a6925067acbb019e3"},"description":"I 2020 uddelte LEO Fondet 72 millioner kr. til forskning i hud og hudsygdomme, LEO Pharma leverede betydelige strategiske fremskridt og accelererede forsknings- og udviklingsaktiviteter samtidig med, at virksomheden n\u00e5ede sine m\u00e5l for driftsresultatet - og afkastet fra investering af fondets formue n\u00e5ede 968 millioner kr. ved udgangen af \u00e5ret.","breadcrumb":{"@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#primaryimage","url":"https:\/\/leo-foundation.org\/da\/wp-content\/uploads\/2021\/03\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg","contentUrl":"https:\/\/leo-foundation.org\/da\/wp-content\/uploads\/2021\/03\/anthony-tori-9qYKMbBCFjc-unsplash_web.jpg","width":2449,"height":1632},{"@type":"BreadcrumbList","@id":"https:\/\/leo-foundation.org\/da\/2021\/03\/25\/aarsrapport-2020-robusthed-og-engagement-i-et-ekstraordinaert-aar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Forside","item":"https:\/\/leo-foundation.org\/da\/"},{"@type":"ListItem","position":2,"name":"\u00c5rsrapport 2020: Robusthed og engagement i et ekstraordin\u00e6rt \u00e5r"}]},{"@type":"WebSite","@id":"https:\/\/leo-foundation.org\/da\/#website","url":"https:\/\/leo-foundation.org\/da\/","name":"LEO Fondet","description":"Endnu en WordPress-blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leo-foundation.org\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Person","@id":"https:\/\/leo-foundation.org\/da\/#\/schema\/person\/3b6acb35625fa72a6925067acbb019e3","name":"signe","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/secure.gravatar.com\/avatar\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bbdf2b5401cc1716c74fa555bf518a86ef8f041c879b444886de237aa0e61ca7?s=96&d=mm&r=g","caption":"signe"}}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"LEO Fondet","distributor_original_site_url":"https:\/\/leo-foundation.org\/da","push-errors":false,"_links":{"self":[{"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/posts\/3411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/comments?post=3411"}],"version-history":[{"count":7,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/posts\/3411\/revisions"}],"predecessor-version":[{"id":4310,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/posts\/3411\/revisions\/4310"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/media\/3412"}],"wp:attachment":[{"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/media?parent=3411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/categories?post=3411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leo-foundation.org\/da\/wp-json\/wp\/v2\/tags?post=3411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}